Atherosclerosis
Volume 194, Issue 2 , Pages e179-e184 , October 2007

Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infraction (MI)

  • Marek Naruszewicz

      Affiliations

    • Department of Pharmacognosy and Molecular Basis of Phythotherapy, Medical University of Warsaw, Ul. Banacha 1, Warszawa, Poland
    • Center for Atherosclerosis Research, Pomeranian Medical University Szczecin, Poland
    • Corresponding Author InformationCorresponding author at: Department of Pharmacognosy and Molecular Basis of Phythotherapy, Medical University of Warsaw, Ul. Banacha 1, Warszawa, Poland. Tel.: +48 22 572 09 86; fax: +48 22 572 09 85.
  • ,
  • Iwona Łaniewska

      Affiliations

    • II Cardiology Clinic, The Medical University of Warsaw, Poland
  • ,
  • Barbara Millo

      Affiliations

    • Center for Atherosclerosis Research, Pomeranian Medical University Szczecin, Poland
  • ,
  • Mirosław Dłużniewski

      Affiliations

    • II Cardiology Clinic, The Medical University of Warsaw, Poland

Received 6 October 2006 ,Revised 6 December 2006 ,Accepted 21 December 2006.

References 

  1. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963–20966
  2. Galle J, Hansen-Hagge T, Wanner Ch, et al. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis. 2006;185:219–226
  3. Han J, Nicholson AC. Lipoproteins modulate expression of the macrophage scavenger receptor. Am J Pathol. 1998;152:1647–1654
  4. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  5. Tomai F, Crea F, Gaspardone A, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation. 2001;104:1471–1476
  6. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20–28
  7. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL-cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352:29–38
  8. Kaplan M, Hayek T, Raz A, et al. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr. 2001;131:2082–2089
  9. Law A, Wu J, Zeng LH, et al. Aortic endothelial cells damage by a nitric oxide donor and protected by flavonoids. Life Sci. 1999;64(19):199–204
  10. Mafei Facino R, Carini M, Aldini G, et al. Procyanidines from Vitis vinifera seeds protect rabbit heart from ischemia/reperfusion injury: antioxidant intervention and/or iron and copper sequestering ability. Planta Medica. 1996;62(6):495–502
  11. Nadiay M, Chataigneau T, Chataigneau M, et al. Red vi8ne polyphenols induce endothelium dependent EDHF-mediated relaxation in procaine coronary arteries via a redox-sensitive mechanism. Biochem Biophys Res Commun. 2003;310:371–377
  12. Oszmiański J, Wojdylo A. Aronia melanocarpa phenolics and their antioxidant activity. Eur Food Res Technol. 2005;221(6):809–813
  13. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004;18:1791–1800
  14. Vassalle C, Botto N, Andreassi MG, et al. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coronary Artery Dis. 2003;14:213–218
  15. Mueller T, Dieplinger B, Gegenhuber A, et al. Serum total 8-isoprostaglandin F2alpha: a new and independent predictor of peripheral arterial disease. J Vasc Surg. 2004;40:768–773
  16. Gross M, Steffes M, Jacobs DR, et al. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA study. Clin Chem. 2005;51:125–131
  17. Wang B, Pan J, Wang L, et al. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis. 2006;184:425–430
  18. Giroux LM, Davignon J, Naruszewicz M. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. Biochim Biophys Acta. 1993;1165:335–338
  19. van Tits LJH, van Himbergen TM, Lemmers HLM, et al. Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia. Atherosclerosis. 2006;185:307–312
  20. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 2005;16:77–84
  21. Maron JM. Flavonoids for reduction of atherosclerotic risk. Curr Atherosclerosis Rep. 2004;6:73–78
  22. Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001;158:195–198
  23. Aviram M, Dornfeld L, Kaplan M, et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res. 2002;28(2/3):49–62
  24. Karim M, McCormick K, Kappagoda T. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr. 2002;130(8):2105S–2108S
  25. Wiswedel I, Hirsch D, Kropf S, et al. Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans. Free Radic Biol Med. 2004;37:411–421
  26. Kim SH, Kang KW, Kim KW, et al. Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci. 2000;67(2):121–131
  27. Aldini G, Carini M, Piccoli A, et al. Procyanidins from grape seeds protect endothelia cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection. Life Sci. 2003;73:2883–2898
  28. Xu J-W, Ikeda K, Yamori Y. Cyanidin-3-glucoside, a typical anthocyanin pigment, induces expression of endothelial nitric oxide synthase trough Src-ERK1/2 signaling pathway. Atherosclerosis. 2003;4(Suppl):281–282
  29. Duffy SJ, Keaney JF, Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001;104:151–156

PII: S0021-9150(07)00029-9

doi: 10.1016/j.atherosclerosis.2006.12.032

Atherosclerosis
Volume 194, Issue 2 , Pages e179-e184 , October 2007